{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:39:51Z","timestamp":1790221191329,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Polish National Centre for Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemical modification of known, effective drugs is one method to improve chemotherapy. Thus, the object of this study was to generate melphalan derivatives with improved cytotoxic activity in human cancer cells (RPMI8226, HL60 and THP1). Several melphalan derivatives were synthesised, modified in their two important functional groups. Nine analogues were tested, including melphalan compounds modified: only at the amino group, by replacing the amine with an amidine group containing a morpholine ring (MOR-MEL) or with an amidino group and dipropyl chain (DIPR-MEL); only at the carboxyl group to form methyl and ethyl esters of melphalan (EM-MEL, EE-MEL); and in a similar manner at both functional groups (EM-MOR-MEL, EE-MOR-MEL, EM-DIPR-MEL, EE-DIPR-MEL). Melphalan derivatives were evaluated for cytotoxicity (resazurin viability assay), genotoxicity (comet assay) and the ability to induce apoptosis (terminal deoxynucleotidyl transferase dUTP nick end labelling, TUNEL, phosphatidylserine externalisation, chromatin condensation, activity of caspases 3\/7, 8 and 9 and intracellular concentration of calcium ions) in comparison with the parent drug. Almost all derivatives, with the exception of MOR-MEL and DIPR-MEL, were found to be more toxic than melphalan in all cell lines evaluated. Treatment of cultures with the derivatives generated a significant higher level of DNA breaks compared to those treated with melphalan, especially after longer incubation times. In addition, all the melphalan derivatives demonstrated a high apoptosis-inducing ability in acute monocytic and promyelocytic leukemia cells. This study showed that the mechanism of action of the tested compounds differed depending on the cell line, and allowed the selection of the most active compounds for further, more detailed investigations.<\/jats:p>","DOI":"10.1038\/s41598-020-61436-x","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:03:11Z","timestamp":1583924591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Chemical modification of melphalan as a key to improving treatment of haematological malignancies"],"prefix":"10.1038","volume":"10","author":[{"given":"Arkadiusz","family":"Gajek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastazja","family":"Poczta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"\u0141ukawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Cecuda- Adamczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tobiasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Marczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"61436_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/asheducation-2017.1.498","volume":"8","author":"MV Mateos","year":"2017","unstructured":"Mateos, M. V. & San Miguel, J. F. Management of multiple myeloma in the newly diagnosed patient. Hematology Am Soc Hematol Educ Program. 8, 498\u2013507 (2017).","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"61436_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1586\/14737140.7.7.945","volume":"7","author":"P Falco","year":"2007","unstructured":"Falco, P. et al. Melphalan and its role in the management of patients with multiple myeloma. Expert Rev Anticancer Ther. 7, 945\u2013957 (2007).","journal-title":"Expert Rev Anticancer Ther."},{"key":"61436_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jsbmb.2013.05.004","volume":"137","author":"P Saha","year":"2013","unstructured":"Saha, P., Debnath, C. & B\u00e9rub\u00e9, G. Steroid-linked nitrogen mustards as potential anticancer therapeutics: a review. J Steroid Biochem Mol Biol. 137, 271\u2013300 (2013).","journal-title":"J Steroid Biochem Mol Biol."},{"key":"61436_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bcp.2006.04.028","volume":"72","author":"K Bielawski","year":"2006","unstructured":"Bielawski, K. et al. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells. Biochem Pharmacol. 72, 320\u2013331 (2006).","journal-title":"Biochem Pharmacol."},{"key":"61436_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ejmech.2018.04.001","volume":"151","author":"RK Singh","year":"2018","unstructured":"Singh, R. K., Kumar, S., Prasad, D. N. & Bhardwaj, T. R. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives. Eur J Med Chem. 151, 401\u2013433 (2018).","journal-title":"Eur J Med Chem."},{"key":"61436_CR6","doi-asserted-by":"crossref","unstructured":"Kuczma, M., Ding, Z. C. & Zhou, G. Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells. Crit Rev Immunol. 2, 179\u2013191 (2016).","DOI":"10.1615\/CritRevImmunol.2016017507"},{"key":"61436_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/cancers11040439","volume":"11","author":"C Gourzones","year":"2019","unstructured":"Gourzones, C. et al. Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells. Cancers (Basel). 11, 439 (2019).","journal-title":"Cancers (Basel)."},{"key":"61436_CR8","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1016\/j.bmcl.2017.10.014","volume":"27","author":"X Hu","year":"2017","unstructured":"Hu, X. et al. Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity. Bioorg Med Chem Lett. 27, 4989\u20134993 (2017).","journal-title":"Bioorg Med Chem Lett."},{"key":"61436_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0140-6736(83)90407-5","volume":"2","author":"JT Carpenter Jr","year":"1983","unstructured":"Carpenter, J. T. Jr. & Maddox, W. A. Melphalan adjuvant therapy in breast cancer. Lancet. 2, 450\u2013451 (1983).","journal-title":"Lancet."},{"key":"61436_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ejps.2013.08.007","volume":"50","author":"A Bogomilova","year":"2013","unstructured":"Bogomilova, A. et al. A polyphosphoester conjugate of melphalan as antitumoral agent. Eur J Pharm Sci. 50, 410\u2013419 (2013).","journal-title":"Eur J Pharm Sci."},{"key":"61436_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.bcp.2013.07.026","volume":"86","author":"S Strese","year":"2013","unstructured":"Strese, S. et al. The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo. Biochem Pharmacol. 86, 888\u2013895 (2013).","journal-title":"Biochem Pharmacol."},{"key":"61436_CR12","first-page":"1935","volume":"35","author":"A Marczak","year":"2015","unstructured":"Marczak, A., Denel-Bobrowska, M., \u0141ukawska, M. & Oszczapowicz, I. Formamidinodoxorubicins are more potent than doxorubicin as apoptosis inducers in human breast cancer cells. Anticancer Research. 35, 1935\u20131940 (2015).","journal-title":"Anticancer Research."},{"key":"61436_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.etap.2014.11.023","volume":"39","author":"A Marczak","year":"2015","unstructured":"Marczak, A., Denel-Bobrowska, M., Rogalska, A., \u0141ukawska, M. & Oszczapowicz, I. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells. Environ Toxicol Pharmacol. 39, 369\u2013383 (2015).","journal-title":"Environ Toxicol Pharmacol."},{"key":"61436_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.taap.2016.10.018","volume":"313","author":"M Denel-Bobrowska","year":"2016","unstructured":"Denel-Bobrowska, M. et al. Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors. Toxicol Appl Pharmacol. 313, 159\u2013169 (2016).","journal-title":"Toxicol Appl Pharmacol."},{"key":"61436_CR15","first-page":"4223","volume":"17","author":"M Denel-Bobrowska","year":"2016","unstructured":"Denel-Bobrowska, M., Lukawska, M., Oszczapowicz, I. & Marczak, A. Histological subtype of ovarian cancer as a determinant of sensitivity to formamidine derivatives of doxorubicin - in vitro comparative studies with SKOV-3 and ES-2 cancer cell lines. Asian Pac J Cancer Prev. 17, 4223\u20134231 (2016).","journal-title":"Asian Pac J Cancer Prev."},{"key":"61436_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s10637-009-9299-4","volume":"28","author":"M Lukawska","year":"2010","unstructured":"Lukawska, M., Wietrzyk, J., Opolski, A., Oszczapowicz, J. & Oszczapowicz, I. Synthesis and biological properties of oxazolinodaunorubicin- a new derivative of daunorubicin with a modified daunosamine moiety. Invest New Drugs. 28, 600\u2013608 (2010).","journal-title":"Invest New Drugs."},{"key":"61436_CR17","first-page":"2959","volume":"32","author":"M Lukawska","year":"2012","unstructured":"Lukawska, M. et al. Oxazolinodoxorubicin - a promising new anthracycline. Anticancer Research. 32, 2959\u20132965 (2012).","journal-title":"Anticancer Research."},{"key":"61436_CR18","first-page":"1429","volume":"29","author":"K Kik","year":"2009","unstructured":"Kik, K., Wasowska-Lukawska, M., Oszczapowicz, I. & Szmigiero, L. Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60\/MX2 resistant cells. Anticancer Res. 29, 1429\u20131433 (2009).","journal-title":"Anticancer Res."},{"key":"61436_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0753-3322(00)00011-1","volume":"55","author":"J Chalas","year":"2001","unstructured":"Chalas, J. et al. Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation. Biomed Pharmacother. 55, 54\u201360 (2001).","journal-title":"Biomed Pharmacother."},{"key":"61436_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","volume":"35","author":"RR Tice","year":"2000","unstructured":"Tice, R. R. et al. Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 35, 206\u2013221 (2000).","journal-title":"Environ Mol Mutagen."},{"key":"61436_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0976-500X.81903","volume":"2","author":"S Nandhakumar","year":"2011","unstructured":"Nandhakumar, S. et al. Evaluation of DNA damage using single-cell gel electrophoresis (Comet Assay). J Pharmacol Pharmacother. 2, 107\u2013111 (2011).","journal-title":"J Pharmacol Pharmacother."},{"key":"61436_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ymeth.2007.11.008","volume":"44","author":"Z Darzynkiewicz","year":"2008","unstructured":"Darzynkiewicz, Z., Galkowski, D. & Zhao, H. Analysis of apoptosis by cytometry using TUNEL assay. Methods. 44, 250\u2013254 (2008).","journal-title":"Methods."},{"key":"61436_CR23","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.7314\/APJCP.2014.15.9.3987","volume":"15","author":"X Xue","year":"2014","unstructured":"Xue, X. et al. Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways. Asian Paci J Cancer Prev. 15, 3987\u20133992 (2014).","journal-title":"Asian Paci J Cancer Prev."},{"key":"61436_CR24","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-16-2426","volume":"23","author":"F Zhou","year":"2017","unstructured":"Zhou, F. et al. Jab1\/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress. Clin Cancer Res. 23, 4450\u20134461 (2017).","journal-title":"Clin Cancer Res."},{"key":"61436_CR25","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1158\/1078-0432.CCR-10-0890","volume":"17","author":"Y Pan","year":"2011","unstructured":"Pan, Y. et al. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clin Cancer Res. 17, 3248\u20133258 (2011).","journal-title":"Clin Cancer Res."},{"key":"61436_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1258\/000456305774538238","volume":"42","author":"SM Harwood","year":"2005","unstructured":"Harwood, S. M., Yaqoob, M. M. & Allen, D. A. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann Clin Biochem. 42, 415\u2013431 (2005).","journal-title":"Ann Clin Biochem."},{"key":"61436_CR27","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/sj.leu.2401871","volume":"14","author":"B Fadeel","year":"2000","unstructured":"Fadeel, B., Orrenius, S. & Zhivotovsky, B. The most unkindest cut of all: on the multiple roles of mammalian caspases. Leukemia. 14, 1514\u20131525 (2000).","journal-title":"Leukemia."},{"key":"61436_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0301-0082(00)00006-X","volume":"62","author":"T Yamashima","year":"2000","unstructured":"Yamashima, T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62, 273\u2013295 (2000).","journal-title":"Prog. Neurobiol."},{"key":"61436_CR29","first-page":"5570","volume":"58","author":"SC Wright","year":"1998","unstructured":"Wright, S. C., Wang, H., Wei, Q. S., Kinder, D. H. & Larrick, J. W. Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation. Cancer Res. 58, 5570\u20135576 (1998).","journal-title":"Cancer Res."},{"key":"61436_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ceca.2011.03.003","volume":"50","author":"B Zhivotovsky","year":"2011","unstructured":"Zhivotovsky, B. & Orrenius, S. Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium. 50, 211\u2013221 (2011).","journal-title":"Cell Calcium."},{"key":"61436_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00925964","volume":"135","author":"P Nicotera","year":"1994","unstructured":"Nicotera, P. & Rossi, A. D. Nuclear Ca2+: physiological regulation and role in apoptosis. Mol. Cell. Biochem. 135, 89\u201398 (1994).","journal-title":"Mol. Cell. Biochem."},{"key":"61436_CR32","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.7314\/APJCP.2015.16.18.8503","volume":"16","author":"A Gajek","year":"2015","unstructured":"Gajek, A. et al. Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells. Asian Pac J Cancer Prev. 16, 8503\u20138512 (2015).","journal-title":"Asian Pac J Cancer Prev."},{"key":"61436_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tiv.2018.12.015","volume":"55","author":"A Gajek","year":"2019","unstructured":"Gajek, A., Rogalska, A. & Koceva-Chy\u0142a, A. Aclarubicin in subtoxic doses reduces doxorubicin cytotoxicity in human non-small cell lung adenocarcinoma (A549) and human hepatocellular carcinoma (HepG2) cells by decreasing DNA damage. Toxicol In Vitro. 55, 140\u2013150 (2019).","journal-title":"Toxicol In Vitro."},{"key":"61436_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tiv.2014.02.007","volume":"28","author":"A Rogalska","year":"2014","unstructured":"Rogalska, A., Gajek, A. & Marczak, A. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells. Toxicol In Vitro. 28, 675\u2013683 (2014).","journal-title":"Toxicol In Vitro."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61436-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:13:00Z","timestamp":1670314380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61436"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61436-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]},"assertion":[{"value":"14 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4479"}}